Orexa B.V.

Orexa B.V. is active in clinical research for anorexia nervosa, with a therapeutic focus on improving food intake, reducing early satiety, and easing postprandial fullness. Its studies address nutritional restraint and the discomfort that can limit eating in affected patients.

• Appetite stimulation
• Satiety reduction
• Gastrointestinal discomfort

The sponsor’s work in this area also extends to underweight older adults, reflecting interest in clinical settings where inadequate intake and impaired nutritional status are central concerns.